Corvus Pharmaceuticals Overview
Corvus Pharmaceuticals Discounted Cash Flow
DCF Analysis for CRVS.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.05
Current Fair Value
$0.05
↓ 99.6% Downside
Overvalued by 99.6% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison